Thrombosis / l tyrosin

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to a series of substituted heteroaromatic compounds, methods for their preparation, pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to bioisosteres of quinoline and quinazoline derivatives which exhibit protein

Axl fusion proteins as Axl tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

REFERENCE TO SEQUENCE LISTING This application contains a Sequence Listing submitted as an electronic text file named " Sequence_Listing.sub.--2848-95-PUS_ST25" having a size in bytes of 183 KB, and created on Sep. 30, 2010. The information contained in this electronic file is hereby incorporated by

Compositions of protein receptor tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

1. FIELD OF THE INVENTION The present invention relates to synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing a family of receptor tyrosine kinases, Tropomysosin Related Kinases (Trk), in particular the

Compositions of protein receptor tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

1. FIELD OF THE INVENTION The present invention relates to synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing a family of receptor tyrosine kinases, Tropomysosin Related Kinases (Trk), in particular the

Compositions of protein receptor tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

1. FIELD OF THE INVENTION The present invention relates to synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing a family of receptor tyrosine kinases, Tropomysosin Related Kinases (Trk), in particular the

Compositions of protein receptor tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

1. FIELD OF THE INVENTION The present invention relates to synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing a family of receptor tyrosine kinases, Tropomysosin Related Kinases (Trk), in particular the

TrkA receptor tyrosine kinase antagonists and uses thereof

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

1. FIELD OF THE DISCLOSURE The present disclosure relates to synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing protein kinase activities. The disclosure further concerns the use of such compounds in the

Methods for treating cancer with TrkA receptor tyrosine kinase antagonists

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

1. FIELD OF THE DISCLOSURE The present disclosure relates to synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing protein kinase activities. The disclosure further concerns the use of such compounds in the

Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

REFERENCE TO SEQUENCE LISTING This application contains a Sequence Listing submitted as an electronic text file named "Sequence_Listing.txt", having a size in bytes of 183 kb, and created on Sep. 30, 2010. The information contained in this electronic file is hereby incorporated by reference in its

Substituted oxindole derivatives as tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION The present invention is related to oxindole derivatives, compositions containing the same, and methods of use and manufacture of the same. Such compounds generally are useful pharmacologically as agents in those disease states alleviated by the alteration of mitogen

Substituted oxindole derivatives as tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION The present invention is related to oxindole derivatives, compositions containing the same, and methods of use and manufacture of the same. Such compounds generally are useful pharmacologically as agents in those disease states alleviated by the alteration of mitogen

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND The present invention is directed to glycosulfopeptides and methods of their use in treating inflammation and disorders related to leukocyte rolling mediated by P-selectin binding. Inflammation is the reaction of vascularized tissue to local injury. This injury can have a variety of

Methods of treatment with Syk inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Arteriosclerosis is a class of diseases characterized by the thickening and hardening of the arterial walls of blood vessels. Although all blood vessels are susceptible to this serious degenerative condition, the aorta and the coronary arteries serving the heart are most

Methods of treatment with Syk inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Arteriosclerosis is a class of diseases characterized by the thickening and hardening of the arterial walls of blood vessels. Although all blood vessels are susceptible to this serious degenerative condition, the aorta and the coronary arteries serving the heart are most

Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION This invention relates to genetically engineered endothelial cells and, in particular, to genetically engineered endothelial cells which exhibit enhanced migration and enhanced plasminogen activator activity. BACKGROUND OF THE INVENTION Endothelial cells are specialized cells

thrombosis/l tyrosin

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

Axl fusion proteins as Axl tyrosine kinase inhibitors

Compositions of protein receptor tyrosine kinase inhibitors

Compositions of protein receptor tyrosine kinase inhibitors

Compositions of protein receptor tyrosine kinase inhibitors

Compositions of protein receptor tyrosine kinase inhibitors

TrkA receptor tyrosine kinase antagonists and uses thereof

Methods for treating cancer with TrkA receptor tyrosine kinase antagonists

Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain

Substituted oxindole derivatives as tyrosine kinase inhibitors

Substituted oxindole derivatives as tyrosine kinase inhibitors

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

Methods of treatment with Syk inhibitors

Methods of treatment with Syk inhibitors

Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird